Get informed when a big investor buys or sells
+ FollowUndervalued by 133.2% based on the discounted cash flow analysis.
Loading insider trades…
Loading congress trades…
| Market cap | $4.53 Billion |
|---|---|
| Enterprise Value | $-233,401,639,961.00 |
| Annual dividend | $2.13 |
| Dividend yield | 5.06% |
| Earnings per Share | $1178.67 |
| Beta | 0.31 |
| Outstanding Shares | 182,388,000 |
| P/E Ratio | 10.31 |
|---|---|
| PEG | -245.82 |
| Price to Sales | 0.0 |
| Price to Book Ratio | 0.0 |
| Enterprise Value to Revenue | 2.3 |
| Enterprise Value to EBIT | 7.36 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.02 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Gedeon Richter Plc is a company focused on the development and manufacturing of pharmaceutical products. Its operations are organized into three primary divisions: Pharmaceuticals, Wholesale & Retail, and Other. The Pharmaceutical segmen...